Skip to Content

News

Printer-friendly PDF version
  • July 16, 2018
    Undergraduates, graduates, and post-doctoral fellows looking to build their knowledge and global perspective in the study of plant-microbe interaction can now do so through a new program called Plant Responses To Eliminate Critical Threats (PRoTECT), hosted by the University of British Columbia’s Michael Smith Laboratories in Canada and the Georg-August-University Göttingen in Germany. Jointly supported by a $1.65 million award (over six years) from the Natural Sciences and Engineering Research Council of Canada (NSERC) through its Collaborative Research and Training Experience (CREATE)...
  • July 10, 2018
    CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vedanta Biosciences, an affiliate of PureTech Health (LSE: PRTC) developing a new category of therapies for immune-mediated and infectious diseases based on rationally defined consortia of human microbiome-derived bacteria, today announced that it has received funding from the Crohn's & Colitis Foundation, a non-profit organization dedicated to finding the cures for Crohn's disease and ulcerative colitis. The funds will be used to advance Vedanta Biosciences’ new microbiome-derived therapeutic program for the treatment and potential...
  • July 2, 2018
    Discovery of the biosynthetic pathway of a plant metabolite lays the groundwork for its use as an anti-diabetes drugDate: July 2, 2018 Source: American Society of Plant Biologists Summary: Montbretin A (MbA), a natural compound with great potential for the treatment of type-2 diabetes, was discovered in the ornamental plant montbretia ten years ago, but it can't be produced on a large scale until its biosynthesis is understood. Scientists have now discovered genes and enzymes responsible for MbA biosynthesis and demonstrated the potential for metabolic engineering of wild tobacco to produce...
  • June 26, 2018
    JAMES BAYLIS, PHD ' 18, BIOMEDICAL ENGINEERING"Engineering at UBC has taught me how vast and mysterious the path is for advancing medical products from proof-of-concept to the clinic."In 2012, I completed my BSc in biophysics at UBC and began graduate studies in biomedical engineering at the Faculty of Applied Science in partnership with the Michael Smith Laboratories. My thesis project, supervised by Dr. Christian Kastrup, is on developing a drug delivery platform which can increase the transport of topically applied therapeutics into wounds, which could increase patient care in trauma...
  • June 18, 2018
    VANCOUVER, British Columbia, June 18, 2018 (GLOBE NEWSWIRE) -- Pascal Biosciences Inc. (TSX-V:PAS) (Pascal), is pleased to announce significant progress in its cannabinoid based research and development program with the University of British Columbia (UBC). Pascal has been licensed by the US Drug Enforcement Administration (DEA) to conduct research and development on cannabinoids. Pascal is also pleased to renew the UBC collaboration and continue financial support of Dr. Wilfred Jefferies' laboratory at the Michael Smith Laboratories.Pascal is one of only a few organizations with a Schedule I...
  • June 5, 2018
    One look at his Twitter account (@Ng_Dave) and you know Dave’s a cool guy. With photos of science experiments, student outreach field trips, and Star Wars GIFs, Dave knows how to make science fun and accessible! A self-proclaimed “science geek” and UBC academic, Dave Ng is the Director of the Advanced Molecular Biology Laboratory (AMBL) the education and outreach facilities at Michael Smith Laboratories (MSL). He runs molecular biology workshops for professionals and science outreach programs for elementary and high-school students, so he definitely knows how to communicate science to the...
  • May 30, 2018
    VANCOUVER, British Columbia--(BUSINESS WIRE)--Microbiome Insights, Inc. has announced the opening of its new laboratory on the campus of the University of British Columbia (UBC). The company, a leading end-to-end service provider for microbiome DNA sequencing and bioinformatic analysis, has expanded into its new state-of-the-art lab in order to meet the needs of over 100 clients. “We have experienced rapid growth in our business and across the microbiome testing industry,” says CEO Malcolm Kendall. “This move is a major milestone for our company and helps us meet the needs of our growing...
  • May 28, 2018
    During this year’s spring graduation, UBC awarded ten honorary degrees for deserving individuals in various fields. Nobel Prize winner, Dr. Peter Agre, was one of the ten individuals to receive UBC’s prestigious honorary degree. Since the first degrees were awarded in 1925, recipients have included Louise Arbour, Emily Carr, His Holiness The Dalai Lama, Julie Payette, Bill Reid, David Suzuki, and many others.Click here to view awarding of Honorary Degree to Dr. Agre.  Dr. Agre is a physician and molecular biologist at Johns Hopkins University, a Bloomberg Distinguished Professor, and the...
  • April 17, 2018
    VANCOUVER, British Columbia, April 17, 2018 (GLOBE NEWSWIRE) -- Renaissance BioScience Corp. (RBSC), a leading global yeast technology company, is pleased to announce a new partnership with Mitacs for a multi-year, $1.44-million research and development project. Mitacs, a national not-for-profit research and training organization, will provide matching funding to the RBSC project to support the development of next-generation, systematic tools and methods for expanding, screening and selecting biodiversity in non-GMO industrial yeast strains.In addition to the work done directly by RBSC, the...
  • April 12, 2018
    LONDON, ON, April 12, 2018 /CNW/ - On Thursday, April 12th, six renowned medical pioneers will be recognized as the 2018 Canadian Medical Hall of Fame Inductees at a special ceremony, hosted in partnership with the Schulich School of Medicine & Dentistry, Western University, including London's own Dr. Vladimir Hachinski, one of the world's leading neurologists who has changed survival odds for stroke sufferers everywhere.Canadian Medical Hall of Fame (CMHF) Inductees are individuals whose contributions have led to extraordinary improvements in human health. Their work may be a single...
Syndicate content